Literature DB >> 26848005

Advanced Innovations for Pain.

Tim J Lamer1, Timothy R Deer2, Salim M Hayek3.   

Abstract

Chronic pain represents one of the most important public health problems in terms of both the number of patients afflicted and health care costs. Most patients with chronic pain are treated with medications as the mainstay of therapy, and yet most medically treated patients continue to report ongoing pain. Additionally, adverse effects from pain medications represent a major challenge for clinicians and patients. Spinal cord stimulation and intrathecal drug delivery systems are well-established techniques that have been utilized for over 25 years. Intrathecal drug delivery systems have proven efficacy for a wide variety of intractable pain conditions and fewer adverse effects than systemic medical therapy in patients with refractory cancer-related pain. Spinal cord stimulation is cost-effective and provides improved pain control compared with medical therapy in patients with a variety of refractory pain conditions including complex regional pain syndrome, painful diabetic neuropathy, and chronic radiculopathy. Patients who have intractable pain that has not responded to reasonable attempts at conservative pain care measures should be referred to a qualified interventional pain specialist to determine candidacy for the procedures discussed in this article.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26848005     DOI: 10.1016/j.mayocp.2015.12.001

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  5 in total

Review 1.  Best Practices for Minimally Invasive Lumbar Spinal Stenosis Treatment 2.0 (MIST): Consensus Guidance from the American Society of Pain and Neuroscience (ASPN).

Authors:  Timothy R Deer; Jay S Grider; Jason E Pope; Tim J Lamer; Sayed E Wahezi; Jonathan M Hagedorn; Steven Falowski; Reda Tolba; Jay M Shah; Natalie Strand; Alex Escobar; Mark Malinowski; Anjum Bux; Navdeep Jassal; Jennifer Hah; Jacqueline Weisbein; Nestor D Tomycz; Jessica Jameson; Erika A Petersen; Dawood Sayed
Journal:  J Pain Res       Date:  2022-05-05       Impact factor: 2.832

Review 2.  Recent advances in understanding and managing cancer pain.

Authors:  Marcin Chwistek
Journal:  F1000Res       Date:  2017-06-20

Review 3.  Current Perspectives on Spinal Cord Stimulation for the Treatment of Cancer Pain.

Authors:  Jonathan M Hagedorn; Thomas P Pittelkow; Christine L Hunt; Ryan S D'Souza; Tim J Lamer
Journal:  J Pain Res       Date:  2020-12-07       Impact factor: 3.133

4.  Retrospective Analysis of Intrathecal Drug Delivery: Outcomes, Efficacy, and Risk for Cancer-Related Pain at a High Volume Academic Medical Center.

Authors:  Dawood Sayed; Forrest Monroe; Walter N Orr; Milind Phadnis; Talal W Khan; Edward Braun; Smith Manion; Andrea Nicol
Journal:  Neuromodulation       Date:  2018-02-14

5.  Neuropathic Pain Medication Use Does Not Alter Outcomes of Spinal Cord Stimulation for Lower Extremity Pain.

Authors:  Dermot P Maher; Yuri Chaves Martins; Tina Doshi; Mark Bicket; Kui Zhang; George Hanna; Shihab Ahmed
Journal:  Neuromodulation       Date:  2017-10-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.